| Item Type | Name |
|
Academic Article
|
Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.
|
|
Academic Article
|
Surgical management of primary and metastatic sarcoma of the mobile spine.
|
|
Academic Article
|
Single-dose palifermin prevents severe oral mucositis during multicycle chemotherapy in patients with cancer: a randomized trial.
|
|
Concept
|
Sarcoma
|
|
Concept
|
Sarcoma, Alveolar Soft Part
|
|
Concept
|
Sarcoma, Synovial
|
|
Concept
|
Sarcoma, Ewing
|
|
Academic Article
|
Rare incidence of congestive heart failure in gastrointestinal stromal tumor and other sarcoma patients receiving imatinib mesylate.
|
|
Academic Article
|
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study.
|
|
Academic Article
|
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas.
|
|
Academic Article
|
Misconceptions with staging of soft tissue sarcoma.
|
|
Academic Article
|
New agents in the treatment of soft-tissue sarcomas.
|
|
Academic Article
|
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation.
|
|
Academic Article
|
Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas.
|
|
Academic Article
|
Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.
|
|
Academic Article
|
Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
|
|
Academic Article
|
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas.
|
|
Academic Article
|
Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma.
|
|
Academic Article
|
New drug developments for patients with metastatic soft tissue sarcoma.
|
|
Academic Article
|
Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected].
|
|
Academic Article
|
Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy.
|
|
Academic Article
|
Adjuvant chemotherapy for soft tissue sarcomas.
|
|
Academic Article
|
Metastatic cancer to the testes: a report of 20 cases and review of the literature.
|
|
Academic Article
|
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma.
|
|
Academic Article
|
Single-agent ifosfamide studies in sarcomas of soft tissue and bone: the M.D. Anderson experience.
|
|
Academic Article
|
Ifosfamide in sarcomas: is it a schedule-dependent drug?
|
|
Academic Article
|
Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution.
|
|
Academic Article
|
Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomas.
|
|
Academic Article
|
New chemotherapeutic strategies for soft tissue sarcomas.
|
|
Academic Article
|
Management of peritoneal and hepatic metastases from gastrointestinal stromal tumors.
|
|
Academic Article
|
Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution.
|
|
Academic Article
|
Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas.
|
|
Academic Article
|
Tumor volume as a prognostic factor for sarcomatosis.
|
|
Academic Article
|
Radiation-induced sarcoma.
|
|
Academic Article
|
Preoperative chemoradiation treatment strategies for localized sarcoma.
|
|
Academic Article
|
Recent advances in systemic therapy of soft tissue sarcomas.
|
|
Academic Article
|
Results of a 2-arm Phase II study of 9-nitrocamptothecin in patients with advanced soft-tissue sarcomas.
|
|
Academic Article
|
A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas.
|
|
Academic Article
|
Recent studies in novel therapy for metastatic sarcomas.
|
|
Academic Article
|
Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment.
|
|
Academic Article
|
Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy.
|
|
Academic Article
|
Soft tissue sarcomas of the popliteal fossa: a single-institution retrospective review.
|
|
Academic Article
|
R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study.
|
|
Academic Article
|
Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study.
|
|
Academic Article
|
The treatment outcome for adult patients with Ewing's sarcoma.
|
|
Academic Article
|
Vascular sarcomas.
|
|
Academic Article
|
Standard and high dose chemotherapy for advanced soft tissue sarcomas.
|
|
Academic Article
|
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.
|
|
Academic Article
|
A revisit of MRI analysis for synovial sarcoma.
|
|
Academic Article
|
Epithelioid sarcoma: results of conservative surgery and radiotherapy.
|
|
Academic Article
|
Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy.
|
|
Academic Article
|
The follow-up of adult soft-tissue sarcomas.
|
|
Academic Article
|
Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.
|
|
Academic Article
|
Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy.
|
|
Academic Article
|
Advances in neoadjuvant chemotherapy in soft tissue sarcomas.
|
|
Academic Article
|
Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma.
|
|
Academic Article
|
Survival in patients with synovial sarcoma of the head and neck: association with tumor location, size, and extension.
|
|
Academic Article
|
Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
|
|
Academic Article
|
Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model.
|
|
Academic Article
|
Sarcomas with spindle cell morphology.
|
|
Academic Article
|
Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
|
|
Academic Article
|
Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial.
|
|
Academic Article
|
Prognostic significance of elevated D-dimer for survival in patients with sarcoma.
|
|
Academic Article
|
Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.
|
|
Academic Article
|
Randomised phase III trial of trabectedin versus doxorubicin-based chemotherapy as first-line therapy in translocation-related sarcomas.
|
|
Academic Article
|
Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor.
|
|
Academic Article
|
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas.
|
|
Academic Article
|
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas.
|
|
Academic Article
|
Spermatic cord sarcoma: outcome, patterns of failure and management.
|
|
Academic Article
|
Preoperative vs. postoperative radiation therapy for soft tissue sarcoma: a retrospective comparative evaluation of disease outcome.
|
|
Academic Article
|
Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma.
|
|
Academic Article
|
Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma.
|
|
Academic Article
|
Phase II Study of Paclitaxel in Patients With Soft Tissue Sarcomas.
|
|
Academic Article
|
Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003.
|
|
Academic Article
|
A 62-year-old woman with osteogenic sarcoma in the contralateral breast 15 years after treatment for breast cancer.
|
|
Academic Article
|
Treatment of the patient with lung metastases.
|
|
Academic Article
|
Radiation Therapy Oncology Group. Research Plan 2002-2006. Sarcoma Committee.
|
|
Academic Article
|
Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma.
|
|
Academic Article
|
Classification of clear-cell sarcoma.
|
|
Academic Article
|
Molecular testing for synovial sarcoma.
|
|
Academic Article
|
Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy.
|
|
Academic Article
|
The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis.
|
|
Academic Article
|
Fifty years of advances in sarcoma treatment: moving the needle from conventional chemotherapy to targeted therapy.
|
|
Academic Article
|
Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience.
|
|
Academic Article
|
Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)?.
|
|
Academic Article
|
Chemotherapy for soft-tissue sarcomas.
|
|
Academic Article
|
Chemotherapy for bone sarcomas in adults: the MD anderson experience.
|
|
Academic Article
|
Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma.
|
|
Academic Article
|
Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
|
|
Academic Article
|
Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma.
|
|
Academic Article
|
Chemotherapy for Bone Sarcoma in Adults.
|
|
Academic Article
|
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor
|
|
Academic Article
|
Soft tissue sarcomas
|
|
Academic Article
|
Treatment of recurrent soft tissue sarcoma
|
|
Academic Article
|
Chemotherapy for soft-tissue sarcomas
|
|
Academic Article
|
Soft Tissue Sarcomas
|
|
Academic Article
|
Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney
|
|
Academic Article
|
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials
|
|
Academic Article
|
Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
|
|
Academic Article
|
Assessment of imaging modalities and response metrics in Ewing sarcoma
|
|
Academic Article
|
Chemotherapy for bone sarcoma in adults
|
|
Academic Article
|
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies
|
|
Academic Article
|
Adult versus pediatric neuroblastoma
|
|
Academic Article
|
Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney: A Single-Institution Experience.
|
|
Academic Article
|
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.
|
|
Academic Article
|
Chemotherapy for soft tissue sarcoma.
|
|
Academic Article
|
Predictors of survival in patients with sarcoma admitted to the intensive care unit.
|
|
Academic Article
|
Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival.
|
|
Academic Article
|
Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials.
|
|
Academic Article
|
Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies.
|
|
Academic Article
|
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.
|
|
Academic Article
|
Clinical trial enrollment of adolescents and young adults with sarcoma.
|
|
Academic Article
|
Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?
|
|
Academic Article
|
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.
|
|
Academic Article
|
Ewing Sarcoma of the Spine: Prognostic Variables for Survival and Local Control in Surgically Treated Patients.
|
|
Academic Article
|
Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.
|
|
Academic Article
|
Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.
|
|
Academic Article
|
Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.
|
|
Academic Article
|
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.
|
|
Academic Article
|
Progressive and Reversible Conduction Disease With Checkpoint Inhibitors.
|
|
Academic Article
|
The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
|
|
Academic Article
|
Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion.
|
|
Academic Article
|
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials.
|
|
Academic Article
|
The challenge of the management of adolescents and young adults with soft tissue sarcomas.
|
|
Academic Article
|
Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report.
|
|
Academic Article
|
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.
|
|
Academic Article
|
Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival.
|
|
Academic Article
|
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy.
|
|
Academic Article
|
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.
|
|
Academic Article
|
MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma.
|
|
Academic Article
|
Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control.
|
|
Academic Article
|
Corrigendum to "SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing Therapy".
|
|
Academic Article
|
Molecular Imaging with 3'-deoxy-3'[(18)F]-Fluorothymidine (18F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study.
|
|
Academic Article
|
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies.
|
|
Academic Article
|
PET/CT Imaging as a Diagnostic Tool in Distinguishing Well-Differentiated versus Dedifferentiated Liposarcoma.
|
|
Academic Article
|
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers.
|
|
Academic Article
|
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic.
|
|
Academic Article
|
Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience.
|
|
Academic Article
|
Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma.
|
|
Academic Article
|
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.
|
|
Academic Article
|
Real-world outcomes of patients with locally advanced or metastatic epithelioid sarcoma.
|
|
Academic Article
|
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
|
|
Academic Article
|
Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
|
|
Academic Article
|
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321.
|
|
Academic Article
|
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma.
|
|
Academic Article
|
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102).
|
|
Academic Article
|
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial.
|
|
Academic Article
|
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma.
|
|
Academic Article
|
The immune landscape of undifferentiated pleomorphic sarcoma.
|
|
Academic Article
|
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101).
|
|
Academic Article
|
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.
|